112 related articles for article (PubMed ID: 1648571)
1. The use of labeled fusion protein for detection of B19 parvovirus IgM antibodies by an immunocapture test.
Morinet F; Courouce AM; Galibert F; Perol Y
J Virol Methods; 1991 Apr; 32(1):21-30. PubMed ID: 1648571
[TBL] [Abstract][Full Text] [Related]
2. Development of an IgM antibody capture test using labelled fusion protein as antigen for diagnosis of B19 human parvovirus infections.
Morinet F; Courouce AM; Galibert F; Perol Y
Behring Inst Mitt; 1990 Aug; (85):28-34. PubMed ID: 2171482
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of commercial enzyme linked immunosorbent assay for detection of B19 parvovirus IgM and IgG.
Patou G; Ayliffe U
J Clin Pathol; 1991 Oct; 44(10):831-4. PubMed ID: 1660053
[TBL] [Abstract][Full Text] [Related]
4. An amplified ELISA for the detection of parvovirus B19 IgM using monoclonal antibody to FITC.
Brown KE; Buckley MM; Cohen BJ; Samuel D
J Virol Methods; 1989 Nov; 26(2):189-98. PubMed ID: 2515204
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-linked immunosorbent assay for IgG and IgM antibodies against human parvovirus B19: use of monoclonal antibodies and viral antigen propagated in vitro.
Yaegashi N; Shiraishi H; Tada K; Yajima A; Sugamura K
J Virol Methods; 1989 Nov; 26(2):171-81. PubMed ID: 2559100
[TBL] [Abstract][Full Text] [Related]
6. New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies.
Schwarz TF; Modrow S; Hottenträger B; Höflacher B; Jäger G; Scharti W; Sumazakl R; Wolf H; Middeldorp J; Roggendorf M
J Clin Microbiol; 1991 Mar; 29(3):431-5. PubMed ID: 1645365
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the specificity of a commercial human parvovirus B19 IgM assay.
Jensen IP; Vestergaard BF
Clin Diagn Virol; 1997 Feb; 7(3):133-7. PubMed ID: 9126681
[TBL] [Abstract][Full Text] [Related]
8. Human parvovirus B19: ELISA and immunoblot assays.
Schwarz TF; Roggendorf M; Deinhardt F
J Virol Methods; 1988 Jun; 20(2):155-68. PubMed ID: 2843558
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a capture enzyme-linked immunosorbent assay for determination of rubella immunoglobulin M using monoclonal antibodies.
Gerna I; Zannino M; Revello MG; Petruzzelli E; Dovis M
J Clin Microbiol; 1987 Jun; 25(6):1033-8. PubMed ID: 3597747
[TBL] [Abstract][Full Text] [Related]
10. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.
Anderson LJ; Tsou C; Parker RA; Chorba TL; Wulff H; Tattersall P; Mortimer PP
J Clin Microbiol; 1986 Oct; 24(4):522-6. PubMed ID: 3021807
[TBL] [Abstract][Full Text] [Related]
11. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
Heegaard ED; Rasksen CJ; Christensen J
J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19.
Fridell E; Cohen BJ; Wahren B
J Clin Microbiol; 1991 Jul; 29(7):1376-81. PubMed ID: 1653264
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis for human parvovirus B19-polyarthritis: usefulness of empty particle B19.ELISA and B19-DNA.PCR].
Hatakeyama Y; Ishii K; Murai C; Sugamura K; Mitomo N; Saitoh T; Rikimaru Y; Okazaki T; Sasaki T
Ryumachi; 1998 Oct; 38(5):689-95. PubMed ID: 9852745
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
15. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen.
Brown CS; van Bussel MJ; Wassenaar AL; van Elsacker-Niele AM; Weiland HT; Salimans MM
J Virol Methods; 1990 Jul; 29(1):53-62. PubMed ID: 2170436
[TBL] [Abstract][Full Text] [Related]
16. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
Kock WC
J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant human parvovirus B19 antigens in serological assays.
Cubie HA; Leslie EE; Smith S; O'Neill HJ; Hart H; Cohen BJ; Inglis JM
J Clin Pathol; 1993 Sep; 46(9):840-5. PubMed ID: 8227436
[TBL] [Abstract][Full Text] [Related]
18. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall.
Hermann J; Demel U; Stünzner D; Daghofer E; Tilz G; Graninger W
Ann Rheum Dis; 2005 Apr; 64(4):641-3. PubMed ID: 15485998
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic of parvovirus B19 infection.
Schwarz TF; Roggendorf M
Behring Inst Mitt; 1990 Aug; (85):35-8. PubMed ID: 2171483
[TBL] [Abstract][Full Text] [Related]
20. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
